0002001557False00020015572026-04-142026-04-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
June 26, 2026
Date of Report (date of earliest event reported)
___________________________________
Innventure, Inc.
(Exact name of registrant as specified in its charter)
___________________________________
| | | | | | | | |
Delaware (State or other jurisdiction of incorporation or organization) | 001-42303 (Commission File Number) | 93-4440048 (I.R.S. Employer Identification Number) |
6900 Tavistock Lakes Blvd, Suite 400 Orlando, Florida 32827 |
(Address of principal executive offices and zip code) |
(321) 209-6787 |
(Registrant's telephone number, including area code) |
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | | | | | | |
Securities registered pursuant to Section 12(b) of the Act: |
Title of each class | Trading Symbol | Name of each exchange on which registered |
Common Stock, par value $0.0001 per share | INV | The Nasdaq Stock Market, LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
Departure of Chief Executive Officer
Effective as of October 1, 2026 (the “Effective Date”), Gregory W. Haskell, Chief Executive Officer of Innventure, Inc. (the “Company”), and a Class I director on the Company’s board of directors (the “Board”), will retire from his position as Chief Executive Officer and as a director. Mr. Haskell’s retirement is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
To ensure a smooth transition, the Company and Mr. Haskell entered into a consulting agreement on June 26, 2026 (the “Consulting Agreement”) for Mr. Haskell to serve as an advisor to the Company beginning on the Effective Date and continuing until July 15, 2027. Pursuant to the Consulting Agreement, the sole consideration for Mr. Haskell’s services will be (a) reimbursement of the cost of premiums for the period from October 1, 2026 through April 30, 2027 associated with his election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), as necessary to continue Mr. Haskell’s and his spouse’s health, dental, and vision coverage through COBRA at the coverage levels in effect immediately prior to his retirement and (b) the vesting of Mr. Haskell’s outstanding equity awards in the Company and Refinity Holdings, LLC (“Refinity”) through the end of the consulting term in accordance with their respective terms. The foregoing description of the Consulting Agreement is not complete and is qualified in its entirety by reference to the full text of the Consulting Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.
Appointment of Chief Executive Officer
In connection with Mr. Haskell’s planned retirement, on June 26, 2026, the Board appointed Dr. William Grieco to serve as Chief Executive Officer of the Company, effective as of the Effective Date. Dr. Grieco was also appointed as a Class I director on the Board, effective as of the Effective Date.
Dr. Grieco, age 54, currently serves as the founding Chief Executive Officer of Refinity, one of the Company's operating companies and a Company subsidiary focused on commercializing technology that transforms plastic waste into valuable chemical intermediaries. He began serving in this role in December 2024. From January 2022 to December 2024, Dr. Grieco served as the Company’s Chief Technology Officer. From July 2018 to December 2021, Dr. Grieco was the Chief Executive Officer of The RAPID Manufacturing Institute®, an organization focused on driving the development and adoption of technologies. Earlier in his career, he held positions at various companies, including Owens Corning and Rohm and Haas Company. Dr. Grieco currently serves as a board member of Refinity and Accelsius Holdings, LLC. He earned a PhD and master’s degree from the Massachusetts Institute of Technology, and a bachelor’s degree from the Georgia Institute of Technology.
Pursuant to a letter agreement dated as of June 26, 2026, between Dr. Grieco and Innventure LLC, the Company’s wholly owned subsidiary (the “Employment Letter”), Dr. Grieco is entitled to receive (i) an annual base salary of $550,000, (ii) an annual cash bonus with a target bonus opportunity equal to 100% of the annual base salary (prorated for 2026), (iii) continued eligibility for a prorated bonus under the 2026 Refinity short-term incentive plan, and (iv) the grant of restricted stock units valued at $1,000,000 upon commencement of his employment on October 1, 2026, with one-third of such restricted stock units vesting on each of the first three anniversaries of the grant date, subject to continued employment. The Employment Letter also provides that Dr. Grieco will be eligible to receive an annual equity grant pursuant to the Company’s long-term incentive program, with the first such annual equity grant expected to be granted in April 2027, have a grant date value of $1,500,000 and consist of a mix of long-term equity compensation vehicles, as ultimately determined and recommended by the Board’s Compensation Committee and approved by the Board. The foregoing description of the Employment Letter is not complete and is qualified in its entirety by reference to the full text of the Employment Letter, a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K.
Further, in connection with Dr. Grieco’s appointment, Dr. Grieco will enter into the Company’s standard form indemnification agreement for executive officers and the Company’s standard form of employee restrictive covenant agreement.
Additional information about the benefit plans and programs described in this Item 5.02, and other plans and programs generally available to the Company’s executive officers, is included in the Company’s Definitive Proxy Statement for the 2026 annual meeting of its stockholders filed with the Securities and Exchange Commission on April 30, 2026.
Item 7.01 Regulation FD Disclosure.
On June 30, 2026, the Company issued a press release announcing the leadership transition. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information provided herein shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| | | | | |
Exhibit Number | Description of Exhibit |
10.1 | Consulting Agreement by and between Gregory W. Haskell and Innventure LLC, dated June 26, 2026 |
10.2 | Employment Letter by and between William Grieco and Innventure LLC, dated June 26, 2026 |
99.1 | Press Release of Innventure, Inc. dated June 30, 2026 |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | |
| | INNVENTURE, INC. |
| | | |
Date: June 30, 2026 | | By: | /s/ David Yablunosky |
| | Name: | David Yablunosky |
| | Title: | Chief Financial Officer |
Innventure Announces Appointment of Dr. Bill Grieco as CEO following Retirement of Current CEO Bill Haskell
Leadership transition to be completed by October 1, 2026
Orlando, FL — June 30, 2026 — Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, today announced that its Board of Directors has appointed Dr. Bill Grieco as Innventure’s next Chief Executive Officer, effective October 1, 2026. Dr. Grieco will succeed Bill Haskell, who is retiring after a distinguished career spanning more than 45 years – the last six of which have been as Innventure’s CEO. Mr. Haskell will work closely with Dr. Grieco to support a seamless transition over the next three months.
The appointment follows a comprehensive succession planning and search process led by a subcommittee of Innventure’s Board, conducted with the assistance of a leading executive search firm that evaluated both internal and external candidates.
“On behalf of the Board, I want to thank Bill Haskell for his leadership and dedication in building Innventure into the platform it is today, and we wish him all the best in his well-earned retirement,” said Mike Otworth, Innventure’s Executive Chairman. “As we enter our next phase of growth, we are excited to welcome Bill Grieco as Chief Executive Officer. Bill is already focused on developing an aggressive first 100 days plan for milestone execution to facilitate Innventure finishing the year strongly. I’m confident that Innventure stakeholders will be pleased by Bill’s transparency and proactive communication to our shareholders and business partners.”
Dr. Grieco currently serves as the founding Chief Executive Officer of Refinity, one of Innventure’s operating companies and as board member of Refinity and Accelsius. From 2022 to 2024, he served as Innventure’s Chief Technology Officer. Prior to Innventure, Dr. Grieco was the CEO of The RAPID Manufacturing Institute® and led R&D for the $3 billion Building Materials Group at Owens Corning. He brings a long history of working alongside multinational corporations to bring differentiated technologies to commercial scale, together with the operating discipline of having led a company through its build-and-scale phase. Dr. Grieco earned a PhD and master’s degree from the Massachusetts Institute of Technology (MIT), and a bachelor’s degree from Georgia Institute of Technology, all in Chemical Engineering.
“I share the Board’s confidence that Bill Grieco is the right leader for Innventure’s next chapter,” said Haskell. “He understands our model from the inside, having helped guide our operating companies at the board level and leading Refinity as CEO. Dr. Grieco was also a key member of the evaluation team that led to the founding of Accelsius. He has been a founding director of Accelsius and continues to sit on the board. Given his depth of knowledge of both Accelsius and Refinity, coupled with his extensive experience co-developing the Innventure model, we think that he has the unique ability to seamlessly lead Innventure. He has earned the trust and respect of our multinational collaboration partners, internal teams, and the Board. I am confident Innventure will be in exceptional hands.”
“I am honored by the Board’s confidence and grateful for everything Bill Haskell has built,” said Dr. Grieco. “Innventure’s model is unique, and it works because it pairs breakthrough technologies with the discipline to launch and grow companies with compelling value propositions. I intend to focus on growing our relationships with multinational partners, scaling our operating companies pragmatically, and creating value for our shareholders.”
Dr. Grieco will join Innventure’s executive committee in connection with his appointment and fill the vacancy created by Mr. Haskell’s planned retirement from Innventure’s Board of Directors on October 1, 2026. He will also continue to serve on the boards of Accelsius and Refinity. Refinity and Innventure are currently working with an executive search firm and our corporate partner to identify a well-qualified successor CEO for Refinity. Dr. Grieco will remain in his role as Refinity CEO until October 1, 2026.
About Innventure
Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises from the ground up, Innventure participates in early-stage economics and provides industrial operating expertise designed for global scale. Innventure’s approach seeks to uniquely bridge the “Valley of Death” between corporate innovation and commercialization through its distinctive combination of value-driven multinational partnerships, operational experience, and scaling expertise.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are often identified by future or conditional words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “will,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on the current assumptions and expectations of future events that are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, those factors described in Innventure’s public filings with the U.S. Securities and Exchange Commission, including but not limited to the following: Innventure’s and its subsidiaries’ ability to execute on their strategies, book sales and achieve future financial performance; developments and projections relating to Innventure’s and its subsidiaries’ competitors and industry; the implementation, adoption, market acceptance and success of Innventure’s and its subsidiaries’ products, business models and growth strategies; Innventure’s and its subsidiaries’ ability to generate sufficient revenue and operating cash flow; the timing and magnitude of expected cash expenditures; the availability, timing and terms of additional financing, including debt or equity financing; market conditions affecting access to capital; potential dilution resulting from future financings; Innventure’s ability to successfully implement cost reduction initiatives; changes in economic conditions; competitive pressures; regulatory developments; Innventure’s ability to maintain control over its subsidiaries.
Forward‑looking statements speak only as of the date of this release, and Innventure undertakes no obligation to update them except as required by law.
Investor Relations Contact: Kyle Nagarkar, Solebury Strategic Communications
investorrelations@innventure.com
Media Contact: Stephanie Knight, Solebury Strategic Communications
press@innventure.com
